Comparison of the BD Viper System With XTR Technology to the Gen-Probe APTIMA COMBO 2 Assay Using the TIGRIS DTS System for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens
Authors:
- Ken BrandtKBKen Brandt
- Nicolette CoffinNCNicolette Coffin
- Paul N. LevettPLPaul N. Levett
- Gregory B. HorsmanGHGregory B. Horsman
- Elliot L. RankERElliot L. Rank
- 1 July 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 39 (7) , 514-517
Abstract
Performances of the BD ProbeTec Chlamydia trachomatis (CT)/Neisseria Gonorrhoeae (GC) Q(x) Amplified DNA Assay reagents on a BD Viper System with XTR Technology and APTIMA COMBO 2 Assay reagents on a TIGRIS DTS platform, for detection of both CT and GC were compared. A total of 1018 first-void urine specimens were tested for the presence of CT and GC DNA using the 2 assays. CT was detected in 143 specimens (14%). Eight specimens exhibited discordant results, and they were divided equally between the 2 assays. Based on the original results, the overall agreement for CT was 99.2%, with 97.1% and 99.5% in agreement with positive and negative specimens, respectively. Cohen's Kappa was 0.967. GC was detected in 27 specimens (2.6%). Two specimens exhibited discordant results, and they were divided equally between the 2 assays. Based on the original results, the overall agreement was 99.8%, with 96.2% and 99.9% in agreement for positive and negative specimens, respectively. Cohen's Kappa was 0.961. There was a high level of agreement between the systems for both CT and GC detection.Keywords
This publication has 15 references indexed in Scilit:
- Clinical Evaluation of the BD ProbeTec™ Chlamydia trachomatis Qx Amplified DNA Assay on the BD Viper™ System With XTR™ TechnologySexually Transmitted Diseases, 2011
- Evaluation of One-Sample Testing of Self-Obtained Vaginal Swabs and First Catch Urine Samples Separately and in Combination for the Detection of Chlamydia trachomatis by Two Amplified DNA Assays in Women Visiting a Sexually Transmitted Disease ClinicSexually Transmitted Diseases, 2011
- Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and cultureSexually Transmitted Infections, 2009
- Reproducibility and specificity concerns associated with nucleic acid amplification tests for detecting Chlamydia trachomatisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Evaluation of Three Automated Nucleic Acid Amplification Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in First-Void Urine SpecimensJournal of Clinical Microbiology, 2008
- Evaluation of CDC-Recommended Approaches for Confirmatory Testing of Positive Neisseria gonorrhoeae Nucleic Acid Amplification Test ResultsJournal of Clinical Microbiology, 2008
- Evaluation of Gen-Probe APTIMA-Based Neisseria gonorrhoeae and Chlamydia trachomatis Confirmatory Testing in a Metropolitan Setting of High Disease PrevalenceJournal of Clinical Microbiology, 2007
- Abilities of APTIMA, AMPLICOR, and ProbeTec Assays To Detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-Based Pap SamplesJournal of Clinical Microbiology, 2007
- Significance of Low Positive Scores Obtained with a Method Other than Acceleration in the BDProbeTec-Strand Displacement Amplification Test for Detection of Neisseria gonorrhoeaeJournal of Clinical Microbiology, 2006
- Detection of Chlamydia trachomatis by Nucleic Acid Amplification Testing: Our Evaluation Suggests that CDC-Recommended Approaches for Confirmatory Testing Are Ill-AdvisedJournal of Clinical Microbiology, 2006